Table 1 Relationship between GOLT1A expression and clinical characteristics in 499 PTC patients from the TCGA database.

From: High GOLT1A expression induces poor prognosis in papillary thyroid carcinoma

Characteristics

GOLT1A

t/χ2

P-value

High expression

Low expression

n = 250

n = 249

Age

36–58

34-58.5

− 0.723

0.47

 ≥ 55 years, n (%)

81 (32.5)

84 (33.7)

0.083

0.775

 < 55 years, n (%)

168 (67.5)

165 (66.3)

  

ETE

6.56

0.01

 Yes, n (%)

90 (37.0)

62 (26.2)

  

 No, n (%)

153 (63.0)

175 (73.8)

  

Sex

0.041

0.84

 Male, n (%)

68 (27.3)

66 (26.5)

  

 Female, n (%)

181 (72.7)

183 (73.5)

  

LNM

4,744

0.029

 Yes, n (%)

125 (54.6)

97 (44.3)

  

 No, n (%)

104 (45.4)

122 (55.7)

  

Histological type

14.755

0.001

 Classical/usual, n (%)

182 (74.6)

172 (70.2)

  

 Follicular, n (%)

36 (14.8)

63 (25.7)

  

 Tall cell, n (%)

26 (10.7)

10 (4.1)

  

Histological risk

6.657

0.01

 High, n (%)

29 (11.6)

13 (5.2)

  

 Low, n (%)

220 (88.4)

236 (94.8)

  

T Stage

1.533

0.216

 T1-T2, n (%)

146 (59.1)

160 (64.5)

  

 T3-T4, n (%)

101 (40.9)

88 (35.5)

  

Pathologic stage

1.933

0.586

 I, n (%)

192 (77.7)

195 (78.6)

  

 II, n (%)

43 (17.4)

45 (18.1)

  

 III, n (%)

10 (4.0)

5 (2.0)

  

 IV, n (%)

2 (0.8)

3 (1.2)

  

Clinical stage

1.264

0.261

 I–II, n (%)

234 (94.7)

240 (96.8)

  

 III–IV, n (%)

13 (5.3)

8 (3.2)

  

Focus

0.518

0.472

 Multifocal, n (%)

116 (47.7)

109 (44.5)

  

 Unifocal, n (%)

127 (52.3)

136 (55.5)

  

Hashimoto’s thyroiditis

0.914

0.339

 Yes, n (%)

29 (12.6)

36 (15.7)

  

 No, n (%)

201 (87.4)

193 (84.3)

  

BRAF Mutation

16.597

< 0.001

 Yes, n (%)

105 (42.5)

148 (60.9)

  

 No, n (%)

142 (57.5)

95 (39.1)

  

Subtype

34.178

< 0.001

 BRAF-like, n (%)

158 (83.6)

112 (56.3)

  

 RAS-like, n (%)

31 (16.4)

87 (43.7)

  

Differentiation risk

28.925

< 0.001

 Yes, n (%)

120 (63.5)

72 (36.2)

  

 No, n (%)

69 (36.5)

127 (63.8)

  

 TDS

− 1.0515 ± 0.168

− 0.561 ± 1.49

− 6.72

< 0.001

  1. GOLT1A, Golgi transport 1 family member A; PTC, papillary thyroid carcinoma; TCGA, The Cancer Genome Atlas; ETE, extrathyroidal extension; LNM, lymph node metastasis; TDS, thyroid differentiation score.